SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Macellum Opportunity Fund LP

(Last) (First) (Middle)
99 HUDSON STREET, 5TH FLOOR

(Street)
NEW YORK NY 10013

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
BIG LOTS INC [ BIG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
Officer (give title below) X Other (specify below)
See Explanation of Responses
3. Date of Earliest Transaction (Month/Day/Year)
04/13/2020
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock $0.01 par value(1) 04/14/2020 X 73,500 A $17.5 926,612 I See Footnote(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Call Options (right to buy) $17.5 04/13/2020 S 675 03/02/2020 04/17/2020 Common Stock $0.01 par value 67,500 $1.8459 157,500 I See Footnote(2)
Call Options (right to buy) $17.5 04/14/2020 S 840 03/02/2020 04/17/2020 Common Stock $0.01 par value 84,000 $1.6729 73,500 I See Footnote(2)
Call Options (right to buy) $17.5 04/14/2020 X 735 03/02/2020 04/17/2020 Common Stock $0.01 par value 73,500 $0 0 I See Footnote(2)
1. Name and Address of Reporting Person*
Macellum Opportunity Fund LP

(Last) (First) (Middle)
99 HUDSON STREET, 5TH FLOOR

(Street)
NEW YORK NY 10013

(City) (State) (Zip)
1. Name and Address of Reporting Person*
Macellum Management, LP

(Last) (First) (Middle)
99 HUDSON STREET
5TH FLOOR

(Street)
NEW YORK NY 10013

(City) (State) (Zip)
1. Name and Address of Reporting Person*
Macellum Advisors GP, LLC

(Last) (First) (Middle)
99 HUDSON STREET
5TH FLOOR

(Street)
NEW YORK NY 10013

(City) (State) (Zip)
1. Name and Address of Reporting Person*
DUSKIN JONATHAN

(Last) (First) (Middle)
MACELLUM CAPITAL MANAGEMENT, LLC
99 HUDSON STREET, 5TH FLOOR

(Street)
NEW YORK NY 10013

(City) (State) (Zip)
Explanation of Responses:
1. This Form 4 is filed jointly by Macellum Opportunity Fund LP ("Macellum Opportunity"), Macellum Management, LP ("Macellum Management"), Macellum Advisors GP, LLC ("Macellum GP") and Jonathan Duskin (collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group that previously owned more than 10% of the Issuer's outstanding shares of Common Stock, par value $0.01 (the "Common Stock"). As of April 14, 2020, the Reporting Persons ceased to own in the aggregate more than 10% of the Issuer's outstanding Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
2. Securities owned directly by Macellum Opportunity. As the investment manager of Macellum Opportunity, Macellum Management may be deemed to beneficially own the securities owned directly by Macellum Opportunity. As the general partner of Macellum Opportunity, Macellum GP may be deemed to beneficially own securities owned directly by Macellum Opportunity. As the sole member of Macellum GP, Mr. Duskin may be deemed to beneficially own the securities owned directly by Macellum Opportunity.
Macellum Opportunity Fund LP; By: Macellum Advisors GP, llc; By: /s/ Jonathan Duskin 04/15/2020
Macellum Management, LP; By: Macellum Advisors GP, LLC; By: /s/ Jonathan Duskin 04/15/2020
Macellum Advisors GP, LLC; By: /s/ Jonathan Duskin 04/15/2020
/s/ Jonathan Duskin 04/15/2020
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.